NDC79622-0010-04: BRINCIDOFOVIR TABLETS.
The BRINCIDOFOVIR TABLETS is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: BRINCIDOFOVIR TABLETS, 4S, 100MG. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-696-1752, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | BRINCIDOFOVIR TABLETS, 4S, 100MG |
| NSN | 6505-01-696-1752 |
| SPECIAL FEATURES | INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULT AND PEDIATRIC PATIENTS, INCLUDING NEONATES; TABLETS ARE BLUE, MODIFIED-OVAL SHAPE, FILM-COATED TABLETS DEBOSSED WITH BCV ON ONE SIDE AND 100 ON THE OTHER SIDE AND PACKAGED INTO BLISTER CARDS; CONTAINS ONE (1) BLISTER CARD WITH A TOTAL OF 4 FILM-COATED TABLETS; STORE AT 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED FROM 15 C TO 30 C (59 F TO 86 F. (SEE USP CONTROLLED ROOM TEMPERATURE); FOR ORAL USE; DO NOT DIVIDE, BREAK, OR CRUSH THE TABLETS; SHELF LIFE: 24 MONTHS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BRINCIDOFOVIR TABLETS, 4S, 100MG |